What Is Myo-Inositol?
Myo-Inositol is the most abundant stereoisomer of inositol and a normal component of cell membranes and intracellular signaling. In reproductive research it is studied as a nutritional signaling compound rather than a peptide: ovarian follicular cells use inositol phosphates to relay insulin and FSH signals, coordinate glucose handling, and support maturation of the oocyte.
Mechanism of Action
Myo-Inositol contributes to phosphatidylinositol second-messenger pathways downstream of the insulin receptor and FSH receptor. In the ovary, this signaling is associated with granulosa-cell glucose uptake, aromatase activity, follicular development, and oocyte maturation. The proposed rationale in PCOS research is improved insulin signaling and restoration of a more coordinated FSH response; it should not be interpreted as a replacement for individualized fertility care.
Quick Reference
Member reference tables summarize the compound's research parameters.
Research Indications
PCOS and Insulin Signaling
Clinical studies commonly investigate Myo-Inositol in PCOS, where insulin resistance and altered gonadotropin signaling can affect ovulation and metabolic markers. Outcomes vary by population and formulation.
Oocyte Quality and Assisted Reproduction
Fertility research examines whether sustained inositol signaling support is associated with follicular response, mature oocyte count, fertilization, and embryo-quality measures during assisted reproduction.
Cycle Regularity and Ovulation
Studies also evaluate cycle length, ovulation frequency, androgen markers, and symptoms in anovulatory or irregular-cycle populations. These endpoints require longitudinal observation rather than short-term subjective assessment.
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Peptide Interactions
This member section summarizes reported compound interactions and evidence limitations.
What to Expect
This member section summarizes reported research time points.
Reported Research Time Points
This member section summarizes reported research time points.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
Quality Indicators
Research Citations
- Myo-inositol effects in women with PCOS: a systematic review and meta-analysis
Systematic review and meta-analysis, 2019. - Inositol treatment and reproductive outcomes in polycystic ovary syndrome
Clinical review, 2018. - International evidence reviews of inositol in PCOS and assisted reproduction
Evidence synthesis; interpret by population, formulation, and endpoint.